Literature DB >> 25624730

Transient elastography improves detection of liver cirrhosis compared to routine screening tests.

Thomas Göbel1, Janine Schadewaldt-Tümmers1, Lucas Greiner1, Christopher Poremba1, Dieter Häussinger1, Andreas Erhardt1.   

Abstract

AIM: To investigate the diagnostic significance of transient elastography (TE) in a daily routine clinical setting in comparison to clinical signs, laboratory parameters and ultrasound.
METHODS: TE, ultrasound, laboratory parameters and cutaneous liver signs were assessed in 291 consecutive patients with chronic liver disease of various aetiologies who underwent liver biopsy in daily routine.
RESULTS: Sensitivity of TE for the detection of liver cirrhosis was 90.4%, compared to 80.1% for ultrasound, 58.0% for platelet count and 45.1% for cutaneous liver signs (P < 0.0001 for comparisons with histology). AUROC for TE was 0.760 (95%CI: 0.694-0.825). Combination of TE with ultrasound increased sensitivity to 96.1% and AUROC to 0.825 (95%CI: 0.768-0.882). TE correlated with laboratory parameters of cirrhosis progression like albumin (r = -0.43), prothrombin time (r = -0.44), and bilirubin (r = 0.34; P < 0.001 for each). Particularly, in patients with Child Pugh score A or normal platelet count TE improved sensitivity for the detection of liver cirrhosis compared to ultrasound by 14.1% (P < 0.04) and 16.3% (P < 0.02), respectively.
CONCLUSION: Transient elastography is superior to routine diagnostic tests allowing detection of liver cirrhosis in additional 10%-16% of patients with chronic liver disease that would have been missed by clinical examinations.

Entities:  

Keywords:  Chronic hepatitis; Fibroscan; Liver cirrhosis; Liver disease; Transient elastography

Mesh:

Substances:

Year:  2015        PMID: 25624730      PMCID: PMC4299349          DOI: 10.3748/wjg.v21.i3.953

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?

Authors:  Nezam H Afdhal
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

3.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

4.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

Review 5.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 7.  Non-invasive evaluation of liver cirrhosis using ultrasound.

Authors:  N Goyal; N Jain; V Rachapalli; D L Cochlin; M Robinson
Journal:  Clin Radiol       Date:  2009-08-14       Impact factor: 2.350

8.  Cirrhosis: diagnosis with sonographic study of the liver surface.

Authors:  A Di Lelio; C Cestari; A Lomazzi; L Beretta
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

9.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  4 in total

1.  Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.

Authors:  Pik Eu Chang; Juanda Leo Hartono; Yee Lin Ngai; Yock Young Dan; Kieron Bl Lim; Wan Cheng Chow
Journal:  Singapore Med J       Date:  2018-12-17       Impact factor: 1.858

2.  The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States.

Authors:  Karn Wijarnpreecha; Elizabeth S Aby; Aijaz Ahmed; Donghee Kim
Journal:  Ann Gastroenterol       Date:  2022-02-15

3.  Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.

Authors:  Philipp Ellinger; Jan Stindt; Carola Dröge; Katharina Sattler; Claudia Stross; Stefanie Kluge; Diran Herebian; Sander H J Smits; Martin Burdelski; Sebastian Schulz-Jürgensen; Antje Ballauff; Jan Schulte Am Esch; Ertan Mayatepek; Dieter Häussinger; Ralf Kubitz; Lutz Schmitt
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

4.  Hepatosplenic schistosomiasis in Zambian adults is characterized by increased liver stiffness: A nested case-control study.

Authors:  Edford Sinkala; Michael Vinikoor; Alice Miyanda Siyunda; Kanekwa Zyambo; Ellen Besa; Bright Nsokolo; Gilles Wandeler; Graham R Foster; Paul Kelly
Journal:  Heliyon       Date:  2020-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.